ATE501280T1 - Verfahren zum nachweis eines analyten in einer biologischen matrix - Google Patents

Verfahren zum nachweis eines analyten in einer biologischen matrix

Info

Publication number
ATE501280T1
ATE501280T1 AT07727792T AT07727792T ATE501280T1 AT E501280 T1 ATE501280 T1 AT E501280T1 AT 07727792 T AT07727792 T AT 07727792T AT 07727792 T AT07727792 T AT 07727792T AT E501280 T1 ATE501280 T1 AT E501280T1
Authority
AT
Austria
Prior art keywords
analyte
detecting
biological matrix
sample
dilution buffer
Prior art date
Application number
AT07727792T
Other languages
English (en)
Inventor
Michael Adler
Original Assignee
Chimera Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38462758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE501280(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chimera Biotec Gmbh filed Critical Chimera Biotec Gmbh
Application granted granted Critical
Publication of ATE501280T1 publication Critical patent/ATE501280T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07727792T 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix ATE501280T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/053323 WO2008122310A1 (en) 2007-04-04 2007-04-04 Method for the detection of an analyte in biological matrix

Publications (1)

Publication Number Publication Date
ATE501280T1 true ATE501280T1 (de) 2011-03-15

Family

ID=38462758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727792T ATE501280T1 (de) 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix

Country Status (6)

Country Link
US (1) US20100291562A1 (de)
EP (1) EP2132339B1 (de)
AT (1) ATE501280T1 (de)
DE (1) DE602007013110D1 (de)
DK (1) DK2132339T3 (de)
WO (1) WO2008122310A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047790A1 (de) * 2008-09-17 2010-04-15 Qiagen Gmbh Verfahren zur Normierung des Gehalts von Biomolekülen in einer Probe
EP2370820B1 (de) 2008-12-31 2016-02-24 Abbott Point Of Care, Inc. Verfahren und vorrichtung für einen immuntest unter verwendung von nukleotidkonjugaten
WO2011047087A2 (en) 2009-10-13 2011-04-21 Nanostring Technologies, Inc. Protein detection via nanoreporters
GB201011971D0 (en) 2010-07-15 2010-09-01 Olink Ab Methods and product
JP5852334B2 (ja) * 2011-06-07 2016-02-03 株式会社日立ハイテクノロジーズ 自動分析方法
DE102014010333A1 (de) 2014-07-14 2016-01-14 Qiagen Gmbh Verfahren zum Nachweis wenigstens eines Zielanalyten in einer Probe
WO2016099999A1 (en) * 2014-12-18 2016-06-23 Ge Healthcare Uk Limited Analyte detection on a solid support by nucleic acid amplification coupled to an immunoassay
RU2018107453A (ru) 2015-08-10 2019-09-12 Эссенликс Корп. Устройства для анализов и способы в биологии/химии, предусматривающие упрощенные стадии, образцы небольшого объема, повышенную скорость и простоту применения
MY194887A (en) 2015-09-14 2022-12-21 Essenlix Corp Device and System for Analyzing a Sample, Particularly Blood, as Well as Methods of Using The Same
KR101982330B1 (ko) 2015-09-14 2019-05-24 에센릭스 코프. 증기 응축액 특히 입김 응축액을 수집 및 분석하기 위한 장치 및 시스템 그리고 이 장치 및 시스템을 사용하는 방법
CA3048002A1 (en) 2016-12-21 2018-06-28 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
JP7003158B2 (ja) 2017-02-07 2022-01-20 エッセンリックス コーポレーション 圧縮開放流アッセイおよび使用
WO2018148764A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Molecular manipulation and assay with controlled temperature
US11927560B2 (en) 2017-02-08 2024-03-12 Essenlix Corporation Bio/chemical material extraction and assay
CA3053005A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
CA3052809A1 (en) 2017-02-08 2018-08-23 Essenlix Corporation Qmax assays and applications
CN120685901A (zh) 2017-02-08 2025-09-23 上海宜晟生物科技有限公司 数字测定
WO2018148607A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Assay using different spacing heights
CN110770572B (zh) 2017-02-09 2023-08-18 Essenlix公司 比色测定
CN110998325B (zh) 2017-02-09 2024-08-16 上海宜晟生物科技有限公司 扩增测定
CA3053295A1 (en) 2017-02-15 2018-08-23 Essenlix Corporation Assay with rapid temperature change
JP7107953B2 (ja) 2017-02-16 2022-07-27 エッセンリックス コーポレーション テクスチャ表面を用いたアッセイ
WO2018231877A1 (en) 2017-06-12 2018-12-20 Essenlix Corporation Homogeneous assay
WO2019028133A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation DEVICES AND METHODS FOR EXAMINING THE EFFECTS OF MEDICINE ON MICROORGANISMS
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
US11243201B2 (en) 2017-08-01 2022-02-08 Essenlix Corporation Sample collection, holding and assaying
US12403465B2 (en) 2017-10-11 2025-09-02 Essenlix Corporation Containing a liquid sample
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
US11510608B2 (en) 2017-12-14 2022-11-29 Essenlix Corporation Devices, systems, and methods for monitoring hair
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5496938A (en) * 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
KR970002255B1 (ko) * 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
ES2113940T3 (es) * 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
EP0529070A1 (de) * 1991-02-27 1993-03-03 Amoco Corporation Verfahren zur verbesserung der empfindlichkeit von hybridisierungsassays
AU662148B2 (en) * 1991-04-10 1995-08-24 Scripps Research Institute, The Heterodimeric receptor libraries using phagemids
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
AU689755B2 (en) * 1992-09-22 1998-04-09 Biofocus Discovery Limited Recombinant viruses displaying a nonviral polypeptide on their external surface
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5496398A (en) * 1994-10-28 1996-03-05 Thiele Kaolin Company Reduction of microorganisms in kaolin clay slurries
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US6665317B1 (en) * 1999-10-29 2003-12-16 Array Telecom Corporation Method, system, and computer program product for managing jitter
US20050079520A1 (en) * 2003-07-21 2005-04-14 Jie Wu Multiplexed analyte detection

Also Published As

Publication number Publication date
EP2132339A1 (de) 2009-12-16
DE602007013110D1 (de) 2011-04-21
WO2008122310A1 (en) 2008-10-16
EP2132339B1 (de) 2011-03-09
US20100291562A1 (en) 2010-11-18
DK2132339T3 (da) 2011-06-27

Similar Documents

Publication Publication Date Title
DE602007013110D1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
EP2883037C0 (de) Verfahren und vorrichtung zur durchführung und quantifizierung von farbveränderungen durch spezifische konzentrationen von biologischen analyten in einer automatisch kalibrierten umgebung
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
ATE479780T1 (de) Qpcr unter verwendung eines ionen-sensitiven feldeffekt-transistors zur ph-messung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
EP1849001A4 (de) Seitenstrom-testsatz und verfahren zum nachweis eines analyten
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
ZA201403386B (en) A method of detecting and/or quantifying an analyte in a biological sample
MY170164A (en) Aptamer-based multiplexed assays
GB2458855A (en) Detection device and methods of use
WO2013157917A3 (en) A biosensor and preparation method thereof
EP2449129A4 (de) Verfahren zur bestimmung des vorhandenseins und/oder der konzentration eines analyts in einer probe
EP2772761A3 (de) Nukleinsäureelement zur Verwendung für Analysen sowie Analyseverfahren, Analysereagens und Analyseinstrument damit
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
ATE541216T1 (de) Fluoreszenztestverfahren
DE602006011917D1 (de) Verfahren und substanzen zur isolierung von mirnas
WO2015059487A3 (en) Detection of cleavage activity of an enzyme
IN2014KN01352A (de)
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
ATE519107T1 (de) Verfahren zur tacrolimus-extraktion und - quantifizierung unter verwendung wässriger detergentien
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
EP2281186A4 (de) Vorrichtung und verfahren zur optischen messung einer analytkonzentration in einer erythrozytenhaltigen flüssigkeit
WO2013121368A3 (en) A process for detection and optional quantification of an analyte
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE550655T1 (de) Verfahren zur bestimmung eines analyten in einer körperflüssigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties